Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
ScaleUP! KC expands impact with 18 entrepreneurs in latest class
In announcing its latest class, the ScaleUP! KC incubator embraced its track record of helping Kansas City entrepreneurs develop the business skills needed to take the next steps on their journeys. Now on its seventh cohort, the program has graduated 92 business owners, including startups like The Sundry, Ruby Jean’s Juicery, Cambrian Tech, H3 Enterprises…
CEO Raina Knox: Millennials don’t have a monopoly on startup momentum
Experience matters — even in an ecosystem built upon disrupting the status quo, said Raina Knox, CEO and co-founder of Stratex Solutions. “It’s uncomfortable for some in the startup community to embrace the concept of people with portfolio careers still having a meaningful impact,” she said, noting her lengthy career as a “fixer” in the…
Cordish’s Spark KC bringing ‘co-living’ concept to Two Light apartments by late 2018
A new co-living concept planned for the Two Light luxury apartment tower will be a game-changer for an evolving generation of entrepreneurs, said Spark KC’s Shervonne Cherry. “With the ability to literally be four stories, five stories, 20-some stories away from your workplace, you don’t have to worry about that commute, allowing you more time…
Hyperloop One exec: KC route would create ‘mega-region’ along I-70
When you’re hoping to move people and freight at near subsonic speeds, it pays to be straightforward. At least that’s the case for Virgin Hyperloop One, which announced Tuesday it has embarked on the feasibility study of a high-speed route that would connect Kansas City and St. Louis in about 30 minutes. “It’s a very…